Wockhardt Q2 FY27: revenue up 23.9% to ₹969 Cr, net profit down 11.0% to ₹73 Cr
Results · Finvezto · 2 Nov 2026 · Wockhardt (WOCKPHARMA)
Results Q2 FY27, ₹ Cr
| Q2 FY27 | ₹ Cr | QoQ | YoY |
|---|---|---|---|
| Revenue | 969 | +4.3% | +23.9% |
| Operating profit | 173 | -9.9% | -2.8% |
| Net profit | 73 | -31.8% | -11.0% |
| Operating margin | 17.9% | -2.8 pp | -4.9 pp |
| Net margin | 7.5% | -4.0 pp | -3.0 pp |
Key points
- Wockhardt Limited reported total revenue of Rs 969 crore for Q2 FY27, up 24% from Rs 782 crore in Q2 FY26, with EBITDA rising to Rs 165 crore from Rs 160 crore and profit after tax declining to Rs 73 crore from Rs 82 crore. NSE filing
- Biotech operations revenue rose 68% year-on-year to Rs 252 crore, while EBITDA excluding pre-Zaynich launch expenses reached Rs 201 crore. NSE filing
- Revenue was ₹969 Cr, up 23.9% on a year earlier and up 4.3% on the quarter before. Finvezto data
What to watch
- Operating margin over the last 4 quarters (Dec 25, Mar 26, Jun 26, Sep 26): 19.9%, 23.3%, 20.7%, 17.9%.
- Net profit over the last 4 quarters (Dec 25, Mar 26, Jun 26, Sep 26), ₹ Cr: 61, 164, 107, 73.
Links
NSE filing (PDF) · Company page · Results tracker
Anand Ganapathy K | SEBI Registered Research Analyst | INH000016630.